07 — The Kidney–Brain Oxalate Axis Series: The Oxalate–Brain Hypothesis Evidence class: Established kidney–brain communication; oxalate-specific psychiatric causation unproven Abstract The kidney and brain are coupled through fluid balance, electrolytes, circulating metabolites, blood pressure, endocrine signaling and inflammation. Oxalate-related kidney injury therefore offers a plausible indirect route to neurological disturbance. The essential question is whether oxalate is acting as a direct neurotoxin, an upstream driver of renal damage, or merely a correlated metabolic measurement. Those explanations must not be collapsed into one. From crystalluria to systemic consequences Hyperoxaluria increases the potential for calcium oxalate supersaturation. Renal tubular crystal deposition can promote epithelial damage, inflammatory signaling and, in severe instances, decline in filtration. Uremic encephalopathy, however, is multifactorial: retained organic solutes, altered neurotransmission, electrolyte and acid–base abnormalities, endothelial dysfunction and medication accumulation may all contribute. An affected patient can show impaired attention, sleep–wake disruption, agitation, disorientation, myoclonus or seizures. These are neurological manifestations of systemic dysfunction, not proof of a primary psychiatric disorder. The causal sequence matters An ideal causal account has at least five separately testable links: an exposure or metabolic defect; increased circulating or excreted oxalate; renal crystallization or tissue injury; changes in filtration or systemic metabolism; and altered cerebral function. Each step has alternative routes. A person may have CKD for reasons unrelated to oxalate; a person with hyperoxaluria may have entirely normal renal function; and a person with depression may have neither. The hypothesis becomes weak when a clinician substitutes a questionnaire about oxalate foods for evidence of these intermediate events. A distinction between encephalopathy and mood disorder Encephalopathy commonly involves attention, level of awareness, fluctuation and global cognitive function. Major depressive disorder or bipolar disorder can present without these phenomena. Symptoms overlap, and serious metabolic illness can contribute to mood problems, but the diagnoses are not interchangeable. A psychiatric presentation with fluctuating consciousness, new neurological signs or severe biochemical abnormality requires urgent medical evaluation; a normal renal panel with persistent affective symptoms points away from a simple kidney-mediated oxalate mechanism. What would strengthen the model? Longitudinal records showing rising oxalate burden before renal deterioration, followed by objective cognitive changes, would be more informative than cross-sectional diet associations. Recovery of mental status as renal physiology normalizes may support a metabolic contribution but would still not isolate oxalate from other retained solutes. The stronger and narrower claim is that oxalate can contribute to renal disease that, if severe enough, can cause brain dysfunction. The weaker and wider claim—that ordinary oxalate intake causes common psychiatric conditions—needs separate evidence. Causal attribution under competing renal syndromes The syndrome of kidney-associated cognitive dysfunction cannot be reduced to one retained metabolite. Renal failure affects drug clearance and the handling of many organic solutes, sodium, acid–base balance and calcium–phosphate physiology. Hypertension, vascular disease and poor sleep may independently alter cognition. Oxalate-related nephropathy might be one initiating kidney disorder among many, while encephalopathy reflects multiple consequences of reduced filtration. An appropriate comparison would examine cognitive trajectories among patients with similar degrees of renal disease but different reasons for the disease. If psychiatric effects were distinctly greater in those with objectively elevated oxalate at comparable filtration and other covariates, an oxalate-specific contribution would become more plausible. If outcomes track renal severity rather than oxalate burden, the more conservative model wins. The question is worth asking precisely because both results would be informative. Conclusion The kidney–brain axis is a legitimate bridge from oxalate physiology to neurological disease. Its scientific value lies in clarifying which disturbances are documented, where the causal chain becomes inferential and when primary psychiatric disease remains the better explanation. Selected readings - Witting et al., Enteric Hyperoxaluria: https://pmc.ncbi.nlm.nih.gov/articles/PMC8011014/ - Mulay et al., Calcium oxalate nephropathy and NLRP3: https://doi.org/10.1172/JCI63679